In 2008, the Lymphoma Research Foundation expanded its first-in-class lymphoma education programming and developed Lymphoma Rounds. Almost two decades since its inaugural program, we're reflecting on the impact that Lymphoma Rounds has had on the healthcare professional community in the latest issue of Pulse: https://lnkd.in/eKtWytGk
Lymphoma Research Foundation’s Post
More Relevant Posts
-
Editor in Chief @ Mediterranean Journal of Hematology and Infectious Diseases | Leading Hematology Scholar
You can see the Progress in treating relapsed Large B Cells with T-CAR cells by reading these two articles: OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT https://lnkd.in/dECECzVr CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA https://lnkd.in/dPSciJi5
To view or add a comment, sign in
-
Recognizing the unmet needs of adolescents and young adults with lymphoma, LRF formed the first-of-its-kind Adolescent and Young Adult Lymphoma Consortium, aimed at advancing the study of AYA lymphomas and improving treatments and care for this patient population. Learn more about LRF's AYA Consortium and the work that they're doing to change the landscape for the youngest lymphoma patients: https://lnkd.in/eU_nexty
To view or add a comment, sign in
-
-
🚨 Did you know? Diffuse large b-cell lymphoma, the most common type of non-Hodgkin’s lymphoma in the US, affects 30,000 new patients each year. With a relapse rate of up to 40% within two years, ongoing advancements in treatment are critical. ✨ Good news is on the horizon: #DLBCL is curable in 60-70% of cases with initial therapy. 🤝 In ACCC’s partnership with The Leukemia and Lymphoma Society we have produced https://bit.ly/3WPkJe5, a guide designed to hone communication, clarify treatment expectations, and help boost patient confidence through shared decision-making. 🔗 https://bit.ly/3wMWJgT Access the guide, a communication road map, and resource library to transform DLBCL treatment and patient engagement. Will you be at #ASCO24? Come visit ACCC’s booth, we’ll see you in Chicago! #LymphomaAwareness #HealthCommunication
To view or add a comment, sign in
-
-
For real change to occur, first we must listen. #VoicesofCTCL features the perspectives of real people living with Cutaneous T-Cell Lymphoma and the doctors who care for them. The 4-part series is now live! Watch here: https://bit.ly/46dnzuG #BloodCancerAwarenessMonth #LookDeeper Cutaneous Lymphoma Foundation
To view or add a comment, sign in
-
-
Lymphoma is the term used for cancer that begins in cells of the lymph system. Non-Hodgkin Lymphoma is the more serious form of this disease, requiring urgent medical intervention in the form of chemotherapy, radiation and stem cell treatment. OPPI & its member companies remain firmly committed towards research and innovation when it comes to finding adequate treatment options for patients suffering from this form of lymphoma. #WorldLymphomaAwarenessDay
To view or add a comment, sign in
-
-
Molecular Imaging Consultant @MNGHA | Dedicated to Teaching and Art | Simplifying Molecular Imaging | Making an Impact | Follow for More
Lymphoma Made Easy👌 Dear all, I am happy to share my third lecture in the PET CT teaching series . This lecture was presented today as part of our local Saudi Fellowship program. After three years of direct interaction with trainees and hematologists, I have started to develop an understanding of what needs to be covered. This lecture might serve as a roadmap for approaching and reporting lymphoma cases. The outline is as follows: - Types of Lymphoma. - Role of PET-CT in lymphoma. - Deauville Score and how to utilize it. -Not all that glitters is lymphoma . - Steps in approaching any lymphoma case. -Latest updates. May these educational resources enhance our practice and contribute to better patient care🙏🏼 Please find the SlideShare link below 👇🏼 https://lnkd.in/dZr-EDFZ
To view or add a comment, sign in
-
-
It’s World Lymphoma Awareness Day. What’s your lymphoma story? Download your #WorldLymphomaAwarenessDay posts 👉 https://lnkd.in/ePJUKc67 #LetsTalkLymphoma #BloodCancerAwarenessMonth #Lymphoma #BloodCancer #LymphomaAwareness #WLAD2023
To view or add a comment, sign in
-
-
Having the right care team can make a difference for people living with Cutaneous T-Cell Lymphoma -- physically and emotionally. Learn more about how doctors and patients are working together: https://bit.ly/45qrQu6 #BloodCancerAwarenessMonth #LookDeeper Cutaneous Lymphoma Foundation
Voices of CTCL: Ron and Carole - Care Team
To view or add a comment, sign in
-
Today is #WorldLymphomaAwarenessDay! From a survey of individuals living with #lymphoma around the world, Lymphoma Coalition found that 82% of individuals experienced psychological and emotional impacts from their diagnosis. Those living with lymphoma also reported higher levels of anxiety during the #COVID19 pandemic. Navigating the mental and emotional impacts of a diagnosis like chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) can be challenging. The prepared questions on this resource document can help patients discuss these challenges with their healthcare team: https://bit.ly/3LntAx0 #WLAD2023
To view or add a comment, sign in
-
-
Expert panelists review recent updates in the management of relapsed/refractory diffuse large B-cell lymphoma and consider how they have impacted the real-world treatment landscape and clinical practice. #oncology #hematology https://lnkd.in/ev2N_rCx
To view or add a comment, sign in